Log in to save to my catalogue

Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms

Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2747979282

Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms

About this item

Full title

Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms

Publisher

Australia: Wiley Subscription Services, Inc

Journal title

Clinical and experimental pharmacology & physiology, 2023-01, Vol.50 (1), p.3-18

Language

English

Formats

Publication information

Publisher

Australia: Wiley Subscription Services, Inc

More information

Scope and Contents

Contents

The incidence of cancer has been growing worldwide. Better survival rates following the administration of novel drugs and new combination therapies may concomitantly cause concern regarding the long‐term adverse effects of cancer therapy, for example, second primary malignancies. Moreover, overcoming tumour resistance to anticancer agents has been...

Alternative Titles

Full title

Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2747979282

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2747979282

Other Identifiers

ISSN

0305-1870

E-ISSN

1440-1681

DOI

10.1111/1440-1681.13725

How to access this item